Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 12Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AFT PHARMS US

02 14CUMBERLAND PHARMS

03 2HALEON US HOLDINGS

04 5HORIZON

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 11534407

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209471

Patent Use Code : U-3553

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-02-27

blank

02

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 11197830

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209471

Patent Use Code : U-3553

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-02-27

blank

03

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 10532036

Drug Substance Claim :

Drug Product Claim :

Application Number : 209471

Patent Use Code : U-3553

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-22

blank

04

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

FAMOTIDINE; IBUPROFEN

US Patent Number : 8067451

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code : U-1196

Delist Requested :

Patent Use Description : RELIEF OF SIGNS AND SY...

Patent Expiration Date : 2026-07-18

blank

05

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

FAMOTIDINE; IBUPROFEN

US Patent Number : 8501228

Drug Substance Claim :

Drug Product Claim :

Application Number : 22519

Patent Use Code : U-1196

Delist Requested :

Patent Use Description : RELIEF OF SIGNS AND SY...

Patent Expiration Date : 2026-07-18

blank

06

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

FAMOTIDINE; IBUPROFEN

US Patent Number : 8318202

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-18

blank

07

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

FAMOTIDINE; IBUPROFEN

US Patent Number : 8309127

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-18

blank

08

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

FAMOTIDINE; IBUPROFEN

US Patent Number : 8449910

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22519

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-07-18

blank

09

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

IBUPROFEN

US Patent Number : 9114068

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-1735

Delist Requested :

Patent Use Description : METHODS OF TREATING PA...

Patent Expiration Date : 2029-09-30

blank

10

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

IBUPROFEN

US Patent Number : 8735452

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-981

Delist Requested :

Patent Use Description : MANAGEMENT OF MILD TO ...

Patent Expiration Date : 2029-09-30

blank